鲁南制药集团与国控陕西、国控青海签署战略合作协议

Group 1 - The core viewpoint of the article is the strategic partnership formed between LuNan Pharmaceutical Group and China National Pharmaceutical Group's Shaanxi and Qinghai subsidiaries, aimed at building a stable, efficient, and sustainable pharmaceutical supply chain in the Northwest region of China [1][3][4] - The "Changying Plan" emphasizes not only commercial sustainability but also a long-term mission to provide high-quality health products and services to the public, marking a significant step in LuNan's regional market strategy [3][4] - The partnership is expected to enhance market competitiveness and service capabilities in Shaanxi, leveraging the strong distribution network and professional logistics services of China National Pharmaceutical Group [3][4] Group 2 - The collaboration will focus on innovative projects such as hospital logistics and patient rehabilitation management, aiming to deepen the integration of brand, channel, and service [3][4] - In Qinghai, the partnership will address the unique challenges of drug accessibility and supply chain stability, with LuNan's diverse product line complementing the local network capabilities of China National Pharmaceutical Group [3][4] - The agreement is positioned to inject strong momentum into the high-quality development of the regional pharmaceutical industry and contribute to the "Healthy China" initiative [4]